中国实用儿科杂志

中国实用儿科杂志 ›› 2025, Vol. 40 ›› Issue (8): 683-687.DOI: 10.19538/j.ek2025080612

• 专题笔谈 • 上一篇    下一篇

儿童重症呼吸道合胞病毒感染诊治进展

  

  1. 四川大学华西第二医院小儿呼吸免疫科  出生缺陷与相关妇儿疾病教育部重点实验室  国家卫生健康委员会时间生物学重点实验室（四川大学），四川  成都  610041
  • 出版日期:2025-08-06 发布日期:2025-09-15
  • 通讯作者: 陈莉娜，电子信箱：chenln66@163.com
  • 基金资助:
    四川省重大科技专项项目（2022ZDZX0021）

Progress in diagnosis and treatment of severe respiratory syncytial virus infection in children

  1. Division of Pediatric Pulmonology and Immunology，West China Second University Hospital，Sichuan University；Key Laboratory of Birth Defects and Related Diseases of Women and Children（Sichuan University），Ministry of Education；NHC Key Laboratory of Chronobiology（Sichuan University），Chengdu  610041，China
  • Online:2025-08-06 Published:2025-09-15

摘要：

呼吸道合胞病毒（respiratory syncytial virus，RSV）是导致儿童下呼吸道感染最常见的病毒，应注意识别有发生重症 RSV 感染风险的高危患儿。临床中有多种确定RSV 感染的检测方法，应合理选择。RSV 感染的治疗以对症支持为主，新近药物研发进展有望实现治疗突破。

关键词:

Abstract:

Respiratory syncytial virus（RSV）is the most common virus causing lower respiratory tract infections in children. Attention should be paid to identifying children at high risk of developing severe infection. There are various detection methods to determine RSV infection，which should be selected rationally. The treatment for RSV infection is mainly symptomatic support，and recent progress in drug research and development is expected to achieve a breakthrough in treatment.

Key words: